BG

B&G Foods, Inc.

BGSConsumer DefensiveNASDAQ

Packaged Foods · Last scanned Oct 26, 2026

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$1.83B
-5.4% YoY
Net Income
-$43.3M
+82.8% YoY
EBITDA
$188.3M
+321.3% YoY
Free Cash Flow
$174.7M

Scan Results

Daily timeframe
5 recent days hidden. Fresh signals are a Premium featureUpgrade →
DateIndicatorDetails
Oct 20▲ RSI OversoldRSI 21.0, below 30, stock may be oversold
Oct 19▲ RSI OversoldRSI 23.1, below 30, stock may be oversold
About B&G Foods, Inc.

Headquartered within the consumer defensive sector, B&G Foods, Inc. focuses on Packaged Foods services and products. B&G Foods, Inc. manufactures, sells, and distributes a portfolio of shelf-stable and frozen foods, and household products in the United States, Canada, and Puerto Rico. Valued at $170.7M, BGS is a micro-cap name in its sector. It operates through Specialty, Meals, Frozen & Vegetables, and Spices & Flavor Solutions segments.

Where BGS stands vs its 150-day and 200-day moving averages

As of the October 20, 2026 close, BGS finished 42.11% below its 150-day moving average ($3.80) and 44.30% below its 200-day moving average ($3.95). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.

Is BGS overbought or oversold?

At the October 20, 2026 close, BGS's RSI(14) was 21.0, in oversold territory (below 30). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.

Key stats
Market Cap$170.7M
Fwd P/E4.07
EPS$-0.88
Beta0.57
52W Change-51.3%
Dividend Yield18.10%
ROE-15.8%
Analysis

On the balance sheet, BGS has $591.6M in cash with $2.58B in obligations. The ability to service this debt comfortably depends on continued operational cash generation. Free cash flow comes in at $174.7M, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. ROE of -15.8% points to negative capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. ROA of 3.9% is on the lower side, which is common in asset-heavy industries. Revenue has pulled back from $2.06B (2021) to $1.83B (2025), a 11% decline worth watching.

BGS's low beta indicates it tends to be less volatile than the broader market, which may suit investors seeking more stable price behavior. No single metric tells the full story. Reviewing BGS's risk profile alongside its fundamentals and technical indicators provides a more complete picture.

Links
More Consumer Defensive stocks
Browse all stocks →
⚠Not financial advice. Scanance shows end-of-day technical indicators (not real-time prices) for information only. Results can be wrong; past performance does not guarantee future results.PrivacyTerms